Montegrande, Marjury .

HRN: 23-25-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2025
CO-AMOXICLAV 625MG (TAB)
04/23/2025
04/30/2025
ORAL
625mg
BID
S/P CS
Waiting Final Action 
04/23/2025
MUPIROCIN 2%, 15G (TUBE)
04/23/2025
04/30/2025
SKIN
2%
BID
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: